Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.25    -0.05 (-0.60%)
Bid:
8.00
Ask:
8.50
Spread: 0.50 (6.25%)
Market Cap: £18.07m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Director/PDMR Shareholding

31 Dec 2009 09:26

RNS Number : 8806E
Phytopharm PLC
31 December 2009
Ā 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anĀ issuerĀ to make aĀ RISĀ notification required byĀ DRĀ 3.1.4R(1).

Ā 

(1)

AnĀ issuerĀ making a notification in respect of a transaction relating to theĀ sharesĀ or debentures of theĀ issuerĀ should complete boxes 1 to 16, 23 and 24.

(2)

AnĀ issuerĀ making a notification in respect of a derivative relatingĀ toĀ theĀ sharesĀ of theĀ issuerĀ should complete boxes 1 to 4, 6, 8,Ā 13, 14, 16, 23 and 24.Ā 

(3)

AnĀ issuerĀ making a notification in respect of options granted to aĀ director/person discharging managerial responsibilitiesĀ should complete boxes 1 to 3 and 17 to 24.Ā 

(4)

AnĀ issuerĀ making a notification in respect of aĀ financial instrumentĀ relating to theĀ sharesĀ of theĀ issuerĀ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Ā 

Ā 

Please complete all relevant boxes in block capital letters.

1.Ā Name of theĀ issuer

PHYTOPHARM PLC

2.Ā State whether the notification relates to (i) a transaction notified in accordance withĀ DRĀ 3.1.4R(1)(a); orĀ (ii)Ā DRĀ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii)

(III) BOTHĀ (I)Ā AND (II)

3.Ā Name ofĀ person discharging managerial responsibilities/director

DR PETER ROBIN BLOWER, NON-EXECUTIVE DIRECTOR

4.Ā State whether notification relates to aĀ personĀ connected with aĀ person discharging managerial responsibilities/directorĀ named in 3 and identify theĀ connected person

AS 3 ABOVE

5.Ā Indicate whether the notification is in respect of a holding of theĀ personĀ referred to in 3 or 4 above or in respect of a non-beneficial interest

AS 3 ABOVE

6.Ā Description ofĀ sharesĀ (includingĀ class), debentures or derivatives or financial instruments relating toĀ shares

ORDINARY SHARES OF 1 PENCE EACH

7.Ā Name of registered shareholders(s) and, if more than one, the number ofĀ sharesĀ held by each of them

AS 3 ABOVE

8Ā State the nature of the transaction

SHARES ACQUIRED

9.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ acquired

75,000

10.Ā Percentage of issuedĀ classĀ acquired (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)

0.02%

11.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ disposed

12.Ā Percentage of issuedĀ classĀ disposed (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)Ā 

13.Ā Price perĀ shareĀ or value of transaction

10Ā PENCE PER SHARE

14.Ā Date and place of transaction

29Ā DecemberĀ 2009, LONDON

15.Ā Total holding following notification and total percentage holding following notification (anyĀ treasury sharesĀ should not be taken into account when calculating percentage)

193,682 - 0.06%

16.Ā Date issuer informed of transaction

30 DECEMBER2009

If aĀ person discharging managerial responsibilitiesĀ has been granted options by theĀ issuerĀ complete the following boxes

17Ā Date of grant

18.Ā Period during which or date on which it can be exercised

19.Ā Total amount paid (if any) for grant of the option

20.Ā Description ofĀ sharesĀ or debentures involved (classĀ and number)

21.Ā Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.Ā Total number ofĀ sharesĀ or debentures over which options held following notification

23.Ā Any additional information

24.Ā Name of contact and telephone number for queries

ZOE MCGOWAN 01480 437697

Name and signature of duly authorised officer ofĀ issuerĀ responsible for making notification

ZOE MCGOWAN

Date of notification

31Ā DECEMBERĀ 2009

ENDĀ 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDSTBBLTMMTJMJL
Date   Source Headline
11th Mar 20142:43 pmRNSDirector/PDMR Shareholding
11th Mar 201410:04 amRNSHolding(s) in Company
7th Mar 20142:35 pmRNSInternational alliance with VirtualScopics
28th Feb 20147:00 amRNSPublication of annual report and business update
6th Feb 20147:00 amRNSAppointment of Joint Broker
13th Jan 20149:51 amRNSPresents at Dementia Challenge seminar in Beijing
2nd Jan 20145:08 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSBusiness and trading update
13th Dec 20137:00 amRNSTSB Grant to Develop Dementia Diagnosis Products
11th Dec 20137:00 amRNSDementia diagnosis tool launch and InHealth update
10th Dec 20137:00 amRNSAttending G8 Global CEO Initiative on Alzheimer's
2nd Dec 201310:03 amRNSIXICO signs MOU with Beijing UMP
18th Nov 20136:00 pmRNSDirector/PDMR Shareholding
1st Nov 20134:01 pmRNSDirector/PDMR Shareholding
31st Oct 201311:26 amRNSDirector/PDMR Shareholding
22nd Oct 201312:29 pmRNSHolding(s) in Company
21st Oct 20131:22 pmRNSDirector/PDMR Shareholding
17th Oct 20133:08 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSFirst Day of Dealings
14th Oct 201312:18 pmRNSResult of General Meeting
14th Oct 201311:08 amRNSSchedule 1 update - Phytopharm Plc
11th Oct 20131:48 pmRNSSch 1 Update - Phytopharm plc
3rd Oct 20139:23 amRNSHolding(s) in Company
1st Oct 20137:00 amRNSDirector/PDMR Shareholding
30th Sep 20132:45 pmRNSSchedule 1 - Phytopharm Plc
27th Sep 20133:17 pmRNSDirector/PDMR Shareholding
24th Sep 20137:30 amRNSRestoration - Phytopharm Plc
23rd Sep 20137:05 amRNSIXICO expands into digital healthcare
23rd Sep 20137:00 amRNSProposed acquisition of IXICO Limited
29th Aug 201312:01 pmRNSSchedule 1 update - Phytopharm plc
9th Aug 20137:00 amRNSInterim Management Statement
8th Aug 201312:23 pmRNSSchedule 1 update - Phytopharm plc
8th Aug 201311:00 amRNSChange to AIM Admission Timetable
6th Aug 20132:15 pmRNSSchedule 1 - Phytopharm plc
5th Aug 20132:16 pmRNSResult of General Meeting
19th Jul 201311:06 amRNSCancellation of Listing and Admission to AIM
23rd May 20137:00 amRNSInterim Results
21st May 20137:45 amRNSStatement re. Suspension
21st May 20137:30 amRNSTemporary Suspension - Phytopharm Plc
17th May 20139:23 amRNSNotice of Results
27th Mar 201310:15 amRNSAGM Statement
26th Mar 20137:00 amRNSStrategic Review Update
15th Mar 201312:06 pmRNSHolding(s) in Company
18th Feb 20137:00 amRNSResearch Update
13th Feb 20131:59 pmRNSHolding(s) in Company
5th Feb 20137:00 amRNSInterim Management Statement
4th Feb 201311:34 amRNSNotice of AGM
19th Dec 20129:21 amRNSAnnual Financial Report
18th Dec 20127:00 amRNSCogane in ALS Update
17th Dec 201211:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.